|
1
|
Sudoh T, Kangawa K, Minamino N and Matsuo
H: A new natriuretic peptide in porcine brain. Nature. 332:78–81.
1988. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
de Lamos JA, McGuire DK and Drazner MH:
B-type natriuretic peptide in cardiovascular disease. Lancet.
362:316–322. 2003.PubMed/NCBI
|
|
3
|
Maisel AS, Krishnaswamy P, Nowak RM, et
al: Rapid measurement of B-type natriuretic peptide in the
emergency diagnosis of heart failure. N Engl J Med. 347:161–167.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McCullough PA, Nowak RM, McCord J, et al:
B-type natriuretic peptide and clinical judgment in emergency
diagnosis of heart failure: analysis from Breathing Not Properly
(BNP) Multinational Study. Circulation. 106:416–422. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Maisel A: B-type natriuretic peptide
levels: diagnostic and prognostic incongestive heart failure:
what's next? Circulation. 105:2328–2331. 2002.
|
|
6
|
Mueller C, Scholer A, Laule-Kilian K, et
al: Use of B-type natriuretic peptide in the evaluation and
management of acute dyspnea. N Engl J Med. 350:647–654. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Morrow DA, de Lemos JA, Sabatine MS, et
al: Evaluation of B-type natriuretic peptide for risk assessment in
unstable angina/non-ST-elevation myocardial infarction: B-type
natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll
Cardiol. 41:1264–1272. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jernberg T, Stridsberg M, Venge P and
Lindahl B: N-terminal pro brain natriuretic peptide on admission
for early risk stratification of patients with chest pain and no
ST-segment elevation. J Am Coll Cardiol. 40:437–445. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
de Lemos JA, Morrow DA, Bentley JH, et al:
The prognostic value of B-type natriuretic peptide in patients with
acute coronary syndromes. N Engl J Med. 345:1014–1021. 2001.
|
|
10
|
Bettencourt P, Azevedo A, Pimenta J,
Friões F, Ferreira S and Ferreira A: N-terminal-pro-brain
natriuretic peptide predicts outcome after hospital discharge in
heart failure patients. Circulation. 110:2168–74. 2004. View Article : Google Scholar
|
|
11
|
Hunt SA, Abraham WT, Chin MH, et al: 2009
focused update incorporated into the ACC/AHA 2005 guidelines for
the diagnosis and management of heart failure in adults: a report
of the American College of Cardiology Foundation/American Heart
Association Task Force on Practice Guidelines: developed in
collaboration with the International Society for Heart and Lung
Transplantation. Circulation. 119:e391–e479. 2009.
|
|
12
|
Cleland JG, McMurray JJ, Kjekshus J, et
al: Plasma concentration of amino-terminal pro-brain natriuretic
peptide in chronic heart failure: prediction of cardiovascular
events and interaction with the effects of rosuvastatin: a report
from CORONA (Controlled Rosuvastatin Multinational Trial in Heart
Failure). J Am Coll Cardiol. 54:1850–1859. 2009.
|
|
13
|
Anderson JL, Adams CD, Antman EM, et al:
ACC/AHA 2007 guidelines for the management of patients with
unstable angina/non ST-elevation myocardial infarction: a report of
the American College of Cardiology/American Heart Association Task
Force on Practice Guidelines (Writing Committee to Revise the 2002
Guidelines for the Management of Patients With Unstable Angina/Non
ST-Elevation Myocardial Infarction): developed in collaboration
with the American College of Emergency Physicians, the Society for
Cardiovascular Angiography and Interventions, and the Society of
Thoracic Surgeons: endorsed by the American Association of
Cardiovascular and Pulmonary Rehabilitation and the Society for
Academic Emergency Medicine. Circulation. 116:e148–e304. 2007.
|
|
14
|
Bassan R, Potsch A, Maisel A, et al:
B-type natriuretic peptide: a novel early blood marker of acute
myocardial infarction in patients with chest pain and no ST-segment
elevation. Eur Heart J. 26:234–240. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Morita E, Yasue H, Yoshimura M, et al:
Increased plasma levels of brain natriuretic peptide in patients
with acute myocardial infarction. Circulation. 88:82–91. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Haaf P, Reichlin T, Corson N, et al:
B-type natriuretic peptide in the early diagnosis and risk
stratification of acute chest pain. Am J Med. 124:444–452. 2011.
View Article : Google Scholar
|
|
17
|
Maisel A, Mueller C, Adams K Jr, et al:
State of the art: using natriuretic peptide levels in clinical
practice. Eur J Heart Fail. 10:824–839. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sabatine MS, Morrow DA, de Lemos JA, et
al: Acute changes in circulating natriuretic peptide levels in
relation to myocardial ischemia. J Am Coll Cardiol. 44:1988–1995.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Staub D, Nusbaumer C, Zellweger MJ, et al:
Use of B-type natriuretic peptide in the detection of myocardial
ischemia. Am Heart J. 151:1223–1230. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Melanson SE, Morrow DA and Jarolim P:
Earlier detection of myocardial injury in a preliminary evaluation
using a new troponin I assay with improved sensitivity. Am J Clin
Pathol. 128:282–286. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Reichlin T, Hochholzer W, Bassetti S, et
al: Early diagnosis of myocardial infarction with sensitive cardiac
troponin assays. N Engl J Med. 361:858–867. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ogawa Y, Nakao K, Mukoyama M, et al:
Natriuretic peptides as cardiac hormone in normotensive and
spontaneously hypertensive rats: the ventricle is a major site of
synthesis and secretion of brain natriuretic peptide. Circ Res.
69:491–500. 1991. View Article : Google Scholar
|
